Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis

BACKGROUND: Use of long-term tobramycin inhalation solution (TIS) has been shown beneficial in cystic fibrosis (CF) and earlier findings also suggest a benefit in non-CF bronchiectasis. We investigated the efficacy and safety of maintenance TIS once daily (OD) in frequent exacerbating bronchiectasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Terpstra, Lotte C., Altenburg, Josje, Bronsveld, Inez, de Kruif, Martijn D., Berk, Yvonne, Snijders, Dominic, Rozemeijer, Wouter, Heijerman, Harry G. M., Boersma, Wim G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719617/
https://www.ncbi.nlm.nih.gov/pubmed/36463180
http://dx.doi.org/10.1186/s12931-022-02243-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719617/
https://www.ncbi.nlm.nih.gov/pubmed/36463180
http://dx.doi.org/10.1186/s12931-022-02243-y

Ejemplares similares